Verify Now!
1-844-728-4929
Pathway Healthcare is excited to announce that Spravato (esketamine) treatment is now available at our Birmingham, Alabama location. This innovative service reflects our commitment to providing cutting-edge, accessible behavioral health care for individuals struggling with treatment-resistant depression and related challenges.
Spravato is an FDA-approved nasal spray designed for adults who have not found relief from depression with traditional medications. Administered under medical supervision, Spravato works differently than standard antidepressants, offering fast-acting relief for those who need it most.
Spravato is specifically designed for individuals with treatment-resistant depression—those who have tried two or more antidepressants without success. For many, depression can feel isolating, overwhelming, and persistent. By introducing Spravato, Pathway Healthcare aims to offer renewed hope and healing to those who need it most.
At Pathway Healthcare, we believe in comprehensive, compassionate care. Spravato is part of our holistic approach to behavioral health, which includes therapy, medication management, and support for those stepping down from residential treatment or inpatient care. We work closely with each individual to develop a personalized treatment plan, ensuring they receive the care and tools needed to thrive.
We are proud to bring this life-changing treatment to Birmingham, Alabama, making quality behavioral health care more accessible than ever. If you or a loved one are struggling with treatment-resistant depression, contact Pathway Healthcare to learn more about how Spravato can help. Together, we can take the next step toward healing and recovery.
Headquarters
1000 Urban Center Drive
Suite 600
Birmingham, AL 35242
1-844-728-4929
Text ‘HOPE’ to 47177
© Pathway Healthcare 2024
Designed by Brandon Sopher